SL52095: Molecular biology of cancer
[Page last updated: 15 May 2025]
Academic Year: | 2025/26 |
Owning Department/School: | Department of Life Sciences |
Credits: | 5 [equivalent to 10 CATS credits] |
Notional Study Hours: | 100 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | EXCB 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: |
Pre requisite knowledge of basic cellular signalling, DNA transcription (eg SL22020 or SL20005 or similar)
In taking this module you cannot take SL32086 |
Learning Outcomes: |
On successful completion of this unit, the student should be able to:
|
Synopsis: | "In this unit you will:
- explore recent advances in molecular and cellular processes underlying tumour development and its treatment.
- develop your knowledge and understanding of the disease process in cancer, and the complexity of its treatment, and give examples of current treatment regimes in particular clinical settings. " |
Content: | The cell and molecular biology driving tumour initiation and progression including tumour suppressor mechanisms and failure in apoptosis, epigenetic changes, activation of oncogenes, angiogenic processes and metastasis, cancer stem cells and cancer immunology. The molecular mechanisms of action of the major classes of drugs currently in use and their shortcomings, including chemotherapies, targeted therapies and novel targets. |
Course availability: |
SL52095 is Optional on the following courses:Department of Life Sciences
|
Notes:
|